FDA Inspection 1270262 — AIT Biosciences

AIT Biosciences — FEI 3009546871

The FDA completed an inspection of AIT Biosciences on Mar 28, 2025 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 28, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Indianapolis, IN (United States)

Additional details

Bioanalytical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.